OBJECTIVE: Studies on long-term nonprogressors (LTNP) have been conducted in the USA and Europe. This study examined the frequency of LTNPs and HIV controllers among 637 HIV-1 seroconverters in rural Uganda. DESIGN AND METHODS: LTNPs were defined as being infected for more than 7 years with a CD4 T-cell count above 600 cells per microliter, and HIV controllers as having undetectable viral loads on 3 separate occasions without antiretroviral treatment. HIV-1 viral load and subtype distribution between LTNP and non-LTNP populations were determined. RESULTS: Of the HIV seroconverters, 9.1% (58/637) were LTNPs and 1.4% (9/637) were HIV controllers. LTNPs had a significantly lower viral load at set point than non-LTNP participants (P < 0.001). The Kaplan-Meier joint probability of surviving to 7 years with a CD4 count >600 was 19.2%. Individuals who survived 7 years had a significantly higher frequency of HIV-1 subtype A (P < 0.05), but seroconverters infected with HIV-1A did not have a significantly higher probability of becoming an LTNP. CONCLUSIONS: The frequency of LTNPs appears to be relatively high in Uganda and it may be important to take this into account when designing studies of viral pathogenesis and performing HIV vaccine trials in sub-Saharan Africa.
OBJECTIVE: Studies on long-term nonprogressors (LTNP) have been conducted in the USA and Europe. This study examined the frequency of LTNPs and HIV controllers among 637 HIV-1 seroconverters in rural Uganda. DESIGN AND METHODS: LTNPs were defined as being infected for more than 7 years with a CD4 T-cell count above 600 cells per microliter, and HIV controllers as having undetectable viral loads on 3 separate occasions without antiretroviral treatment. HIV-1 viral load and subtype distribution between LTNP and non-LTNP populations were determined. RESULTS: Of the HIV seroconverters, 9.1% (58/637) were LTNPs and 1.4% (9/637) were HIV controllers. LTNPs had a significantly lower viral load at set point than non-LTNP participants (P < 0.001). The Kaplan-Meier joint probability of surviving to 7 years with a CD4 count >600 was 19.2%. Individuals who survived 7 years had a significantly higher frequency of HIV-1 subtype A (P < 0.05), but seroconverters infected with HIV-1A did not have a significantly higher probability of becoming an LTNP. CONCLUSIONS: The frequency of LTNPs appears to be relatively high in Uganda and it may be important to take this into account when designing studies of viral pathogenesis and performing HIV vaccine trials in sub-Saharan Africa.
Authors: J Tang; C Rivers; E Karita; C Costello; S Allen; P N Fultz; E E Schoenbaum; R A Kaslow Journal: Genes Immun Date: 1999-09 Impact factor: 2.676
Authors: B A Koblin; B H van Benthem; S P Buchbinder; L Ren; E Vittinghoff; C E Stevens; R A Coutinho; G J van Griensven Journal: Am J Epidemiol Date: 1999-11-15 Impact factor: 4.897
Authors: Matthew J Dolan; Hemant Kulkarni; Jose F Camargo; Weijing He; Alison Smith; Juan-Manuel Anaya; Toshiyuki Miura; Frederick M Hecht; Manju Mamtani; Florencia Pereyra; Vincent Marconi; Andrea Mangano; Luisa Sen; Rosa Bologna; Robert A Clark; Stephanie A Anderson; Judith Delmar; Robert J O'Connell; Andrew Lloyd; Jeffrey Martin; Seema S Ahuja; Brian K Agan; Bruce D Walker; Steven G Deeks; Sunil K Ahuja Journal: Nat Immunol Date: 2007-10-21 Impact factor: 25.606
Authors: Hermann Bussmann; C William Wester; Kereng V Masupu; Trevor Peter; Sarah M Gaolekwe; Soyeon Kim; Ann Marie Reich; Sam Ahn; Ying Wu; Ibou Thior; Max Essex; Richard Marlink Journal: Clin Diagn Lab Immunol Date: 2004-09
Authors: Florencia Pereyra; Marylyn M Addo; Daniel E Kaufmann; Yang Liu; Toshiyuki Miura; Almas Rathod; Brett Baker; Alicja Trocha; Rachel Rosenberg; Elizabeth Mackey; Peggy Ueda; Zhigang Lu; Daniel Cohen; Terri Wrin; Christos J Petropoulos; Eric S Rosenberg; Bruce D Walker Journal: J Infect Dis Date: 2008-02-15 Impact factor: 5.226
Authors: Tom Lutalo; Ronald H Gray; Maria Wawer; Nelson Sewankambo; David Serwadda; Oliver Laeyendecker; Noah Kiwanuka; Fred Nalugoda; Godfrey Kigozi; Anthony Ndyanabo; John Baptist Bwanika; Steven J Reynolds; Tom Quinn; Pius Opendi Journal: AIDS Date: 2007-11 Impact factor: 4.177
Authors: Noah Kiwanuka; Oliver Laeyendecker; Merlin Robb; Godfrey Kigozi; Miguel Arroyo; Francine McCutchan; Leigh Anne Eller; Michael Eller; Fred Makumbi; Deborah Birx; Fred Wabwire-Mangen; David Serwadda; Nelson K Sewankambo; Thomas C Quinn; Maria Wawer; Ronald Gray Journal: J Infect Dis Date: 2008-03-01 Impact factor: 5.226
Authors: Marylyn M Addo; Rika Draenert; Almas Rathod; Cori L Verrill; Benjamin T Davis; Rajesh T Gandhi; Gregory K Robbins; Nesli O Basgoz; David R Stone; Daniel E Cohen; Mary N Johnston; Theresa Flynn; Alysse G Wurcel; Eric S Rosenberg; Marcus Altfeld; Bruce D Walker Journal: PLoS One Date: 2007-03-28 Impact factor: 3.240
Authors: Ishla Seager; Simon A Travers; Michael D Leeson; Amelia C Crampin; Neil French; Judith R Glynn; Grace P McCormack Journal: AIDS Res Hum Retroviruses Date: 2014-07-29 Impact factor: 2.205
Authors: Ishla Seager; Michael D Leeson; Amelia C Crampin; Dominic Mulawa; Neil French; Judith R Glynn; Simon A A Travers; Grace P McCormack Journal: AIDS Res Hum Retroviruses Date: 2011-08-30 Impact factor: 2.205
Authors: Andrew D Redd; Oliver Laeyendecker; Xiangrong Kong; Noah Kiwanuka; Tom Lutalo; Wei Huang; Ronald H Gray; Maria J Wawer; David Serwadda; Susan H Eshleman; Thomas C Quinn Journal: AIDS Res Hum Retroviruses Date: 2011-08-05 Impact factor: 2.205
Authors: Mariya V Sivay; Jessica M Fogel; Jing Wang; Yinfeng Zhang; Estelle Piwowar-Manning; William Clarke; Autumn Breaud; Joel Blankson; Erica L Hamilton; Kathleen Kahn; Amanda Selin; F Xavier Gomez-Olive; Catherine MacPhail; James P Hughes; Audrey Pettifor; Susan H Eshleman Journal: HIV Clin Trials Date: 2018-12-06
Authors: Andrew D Redd; Caroline E Mullis; David Serwadda; Xiangrong Kong; Craig Martens; Stacy M Ricklefs; Aaron A R Tobian; Changchang Xiao; Mary K Grabowski; Fred Nalugoda; Godfrey Kigozi; Oliver Laeyendecker; Joseph Kagaayi; Nelson Sewankambo; Ronald H Gray; Stephen F Porcella; Maria J Wawer; Thomas C Quinn Journal: J Infect Dis Date: 2012-06-05 Impact factor: 5.226
Authors: Vernon Mochache; Barbra A Richardson; Linnet N Masese; Susan M Graham; Kishorchandra Mandaliya; John Kinuthia; Walter Jaoko; Julie Overbaugh; R Scott McClelland Journal: Int J STD AIDS Date: 2020-04-15 Impact factor: 1.359
Authors: Alex Kayongo; Elena Gonzalo-Gil; Emrah Gümüşgöz; Anxious J Niwaha; Fred Semitala; Robert Kalyesubula; Bernard S Bagaya; Moses L Joloba; Richard E Sutton Journal: J Acquir Immune Defic Syndr Date: 2018-11-01 Impact factor: 3.731